Korean J Psychopharmacol.  2014 Oct;25(4):175-185. 10.0000/kjp.2014.25.4.175.

Korean Pharmacological Treatment Guideline for Child-Adolescent Depression: The Efficacy and Choice of Antidepressant

Affiliations
  • 1Department of Psychiatry, Yeouido St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea. tyjun@catholic.ac.kr
  • 2Clinical Research Center for Depression, Seoul, Korea.
  • 3Medical Library, College of Medicine, The Catholic University of Korea, Seoul, Korea.
  • 4Department of Preventive Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea.
  • 5Department of Psychiatry, Soonchunhyang University Bucheon Hospital, College of Medicine, Soonchunhyang University, Bucheon, Korea.

Abstract


OBJECTIVE
The purpose of this guideline was to suggest recommendations for appropriate use of antidepressants in the child-adolescent depression. The differences of efficacy among antidepressants were evaluated.
METHODS
Four kinds of reliable guidelines for the treatments of child-adolescent depression had been selected, and evidences and recommendations were extracted by the executive committee under the peer review. All the process was applied to the Manual for Guideline Adaptation version 2.0 by National Evidence-based Healthcare Collaborating Agency.
RESULTS
Selective serotonin reuptake inhibitor (SSRI) could be considered for the treatments of moderate to severe child-adolescent depression. Among SSRIs, fluoxetine, sertraline, and escitalopram were recommended as having antidepressant efficacy compared with placebo, while paroxetine, venlafaxine, and tricyclic antidepressant were not recommended owing to lack of evidence. Another recommendation was to use combined treatment with cognitive behavioral therapy.
CONCLUSION
This guideline, which was made through former and strict process of guideline adaptation, would contribute toward improving the quality of child-adolescent depression treatment by providing useful recommendations for the choice of antidepressant.

Keyword

Depression; Child; Adolescent; Pharmacological treatment; Antidepressant

MeSH Terms

Adolescent
Antidepressive Agents
Child
Citalopram
Cognitive Therapy
Delivery of Health Care
Depression*
Fluoxetine
Humans
Paroxetine
Peer Review
Serotonin
Sertraline
Venlafaxine Hydrochloride
Antidepressive Agents
Citalopram
Fluoxetine
Paroxetine
Serotonin
Sertraline
Full Text Links
  • KJP
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr